Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Ottawa

$27,000.00

Exploring Potential Synergic Effects of Exercise with Theta Burst Stimulation in People with Treatment Resistant Depression

EF 2024-25

Résumé
In 2008, the World Health Organization ranked major depressive disorder (MDD) as the third leading cause of global disease burden, with projections indicating it will become the leading cause by 2030. Treatment-resistant depression (TRD), affecting 35-50% of MDD patients, presents a significant challenge. Repetitive transcranial magnetic stimulation (rTMS) is an effective treatment for TRD and is now recommended for patients who have not responded to antidepressants. Theta Burst Stimulation (TBS), a newer rTMS protocol, offers advantages in treatment time while maintaining effectiveness. Combining TBS with other treatments, such as physical activity, may enhance its benefits. A 2023 review highlighted that individuals with depression are especially likely to benefit from physical activity. The aim of this study is to explore the potential synergistic effects of exercise priming combined with TBS on depressive symptoms, including fatigue, sleep disturbances, motivation, and energy levels, in individuals with TRD. The study will also investigate underlying brain plasticity and neural functioning mechanisms. A randomized control trial will include two phases: a priming phase (four weeks of aerobic and strength training) and a synergistic phase (exercise combined with TBS for six weeks). Participants will be assessed at baseline, after the priming phase, and after the synergistic phase, with follow-up evaluations at 6, 12, and 24 weeks. The primary outcomes will be measured using scales for fatigue, energy, motivation, and sleep quality, while TMS will assess neuroplasticity. This research aims to contribute to better treatments for those affected by TRD.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
530092
Name
Pourlotfi Shida
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Exploring Potential Synergic Effects of Exercise with Theta Burst Stimulation in People with Treatment Resistant Depression
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Brain Priming; Exercise Priming; Major Depressive Disorder; Mental Health; Neuroscience; Non-Invasive Brain Stimulation; Repetitive Transcranial Magnetic Stimulation; Synergic Effects; Theta Burst Stimulation; Treatment Resistant Depression
Abstract
In 2008, the World Health Organization ranked major depressive disorder (MDD) as the third leading cause of global disease burden, with projections indicating it will become the leading cause by 2030. Treatment-resistant depression (TRD), affecting 35-50% of MDD patients, presents a significant challenge. Repetitive transcranial magnetic stimulation (rTMS) is an effective treatment for TRD and is now recommended for patients who have not responded to antidepressants. Theta Burst Stimulation (TBS), a newer rTMS protocol, offers advantages in treatment time while maintaining effectiveness. Combining TBS with other treatments, such as physical activity, may enhance its benefits. A 2023 review highlighted that individuals with depression are especially likely to benefit from physical activity. The aim of this study is to explore the potential synergistic effects of exercise priming combined with TBS on depressive symptoms, including fatigue, sleep disturbances, motivation, and energy levels, in individuals with TRD. The study will also investigate underlying brain plasticity and neural functioning mechanisms. A randomized control trial will include two phases: a priming phase (four weeks of aerobic and strength training) and a synergistic phase (exercise combined with TBS for six weeks). Participants will be assessed at baseline, after the priming phase, and after the synergistic phase, with follow-up evaluations at 6, 12, and 24 weeks. The primary outcomes will be measured using scales for fatigue, energy, motivation, and sleep quality, while TMS will assess neuroplasticity. This research aims to contribute to better treatments for those affected by TRD.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Pourlotfi, Shida
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~